APA (7th ed.) Citation

C, C., J, F., N, P., A, C., P, I., A, V., . . . E, F. (2023). Dynamic changes in circulating tumor DNA assessed by shallow whole-genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC. Molecular oncology, 17(5), 779. https://doi.org/10.1002/1878-0261.13409

Chicago Style (17th ed.) Citation

C, Carbonell, et al. "Dynamic Changes in Circulating Tumor DNA Assessed by Shallow Whole-genome Sequencing Associate with Clinical Efficacy of Checkpoint Inhibitors in NSCLC." Molecular Oncology 17, no. 5 (2023): 779. https://doi.org/10.1002/1878-0261.13409.

MLA (9th ed.) Citation

C, Carbonell, et al. "Dynamic Changes in Circulating Tumor DNA Assessed by Shallow Whole-genome Sequencing Associate with Clinical Efficacy of Checkpoint Inhibitors in NSCLC." Molecular Oncology, vol. 17, no. 5, 2023, p. 779, https://doi.org/10.1002/1878-0261.13409.